mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
Автори: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Nature Portfolio
2022-08-01
|
Серія: | npj Vaccines |
Онлайн доступ: | https://doi.org/10.1038/s41541-022-00511-y |
Схожі ресурси
Схожі ресурси
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
за авторством: Susanne Rauch, та інші
Опубліковано: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
за авторством: Nicole Roth, та інші
Опубліковано: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
за авторством: Charlie Fricke, та інші
Опубліковано: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
за авторством: Nicole Roth, та інші
Опубліковано: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
за авторством: Björn Corleis, та інші
Опубліковано: (2023-02-01)